Literature DB >> 25242110

Comment to the article "ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity" by Sreih AG et al.

Luis Felipe Flores-Suárez1, Natllely Ruiz2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25242110     DOI: 10.1007/s10067-014-2784-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Clinical manifestations and treatment of Wegener's granulomatosis.

Authors:  Julia U Holle; Martin Laudien; Wolfgang L Gross
Journal:  Rheum Dis Clin North Am       Date:  2010-08       Impact factor: 2.670

2.  [Clinical features of Wegener granulomatosis and microscopic polyangiitis in Chilean patients].

Authors:  Marcela Cisternas; Lilian Soto; Sergio Jacobelli; María Angélica Marinovic; Alex Vargas; Elizabeth Sobarzo; Jorge Saavedra; Karina Chauan; Gabriela Meléndez; Carolina Foster; Daniel Pacheco; Eduardo Wainstein
Journal:  Rev Med Chil       Date:  2005-05-05       Impact factor: 0.553

3.  Spectrum of Wegener granulomatosis in a Mexican population.

Authors:  Luis Felipe Flores-Suárez; Antonio R Villa
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

4.  Wegener's granulomatosis: experience from a Brazilian tertiary center.

Authors:  Fernando Henrique Carlos de Souza; Ari Stiel Radu Halpern; Carmen Silvia Valente Barbas; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2010-03-01       Impact factor: 2.980

5.  ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity.

Authors:  Antoine G Sreih; Ranadeep Mandhadi; Fadi Aldaghlawi; Asad Khan; Vajiha Irshad; Katherine Finn; Joel A Block
Journal:  Clin Rheumatol       Date:  2014-04-22       Impact factor: 2.980

Review 6.  The prevalence of nonalcoholic fatty liver disease in the Americas.

Authors:  Jorge A López-Velázquez; Karen V Silva-Vidal; Guadalupe Ponciano-Rodríguez; Norberto C Chávez-Tapia; Marco Arrese; Misael Uribe; Nahum Méndez-Sánchez
Journal:  Ann Hepatol       Date:  2014 Mar-Apr       Impact factor: 2.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.